Post marketing surveillance (PMS) is a critical component in the lifecycle of a vaccine. Once a vaccine is approved and distributed to the public, PMS continues to monitor its safety and effectiveness. This process identifies any adverse events or long-term effects that may not have been apparent during clinical trials.
